Search Results - "KALTENBACH, LISA A."

Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality by Mathews, Robin, Wang, William, Kaltenbach, Lisa A, Thomas, Laine, Shah, Rashmee U, Ali, Murtuza, Peterson, Eric D, Wang, Tracy Y

“…BACKGROUND:Medication adherence is important to improve the long-term outcomes after acute myocardial infarction (MI). We hypothesized that there is…”
Get full text

Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis by Armstrong, Ehrin J., MD, Feldman, Dmitriy N., MD, Wang, Tracy Y., MD, MHS, MS, Kaltenbach, Lisa A., MS, Yeo, Khung-Keong, MBBS, Wong, S. Chiu, MD, Spertus, John, MD, Shaw, Richard E., PhD, Minutello, Robert M., MD, Moussa, Issam, MD, Ho, Kalon K.L., MD, Rogers, Jason H., MD, Shunk, Kendrick A., MD, PhD

“…Objectives The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST)…”
Get full text

Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial by Rymer, Jennifer A, Wegermann, Zachary K, Kaltenbach, Lisa A, Webb, Laura E, Peterson, Eric D, Wang, Tracy Y

“…Background Premature discontinuation of P2Y12 inhibitor therapy has been associated with adverse cardiac events, which might be preventable by improving…”
Get full text

Patient-focused intervention to improve long-term adherence to evidence-based medications: A randomized trial by Calvert, Sara Bristol, PharmD, Kramer, Judith M., MD, MS, Anstrom, Kevin J., PhD, Kaltenbach, Lisa A., MS, Stafford, Judith A., MS, Allen LaPointe, Nancy M., PharmD

“…Background Nonadherence to cardiovascular medications is a significant public health problem. This randomized study evaluated the effect on medication…”
Get full text

Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS by Rymer, Jennifer A., Kaltenbach, Lisa A., Peterson, Eric D., Cohen, David J., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cannon, Christopher P., Wang, Tracy Y.

“…Background Persistence to P2Y12 inhibitors after myocardial infarction (MI) remains low. Out‐of‐pocket cost is cited as a factor affecting medication…”
Get full text

Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease by Rymer, Jennifer A, Kaltenbach, Lisa A, Doll, Jacob A, Messenger, John C, Peterson, Eric D, Wang, Tracy Y

“…Background Although recommended in the guidelines, the safety of chronic P2Y inhibitor therapy in patients with chronic kidney disease ( CKD ) after an acute…”
Get full text

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study by Fanaroff, Alexander C., Kaltenbach, Lisa A., Peterson, Eric D., Hess, Connie N., Cohen, David J., Fonarow, Gregg C., Wang, Tracy Y.

“…Background Angina has important implications for patients’ quality of life and healthcare utilization. Angina management after acute myocardial infarction (MI)…”
Get full text

Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs by Doll, Jacob A, Kaltenbach, Lisa A, Anstrom, Kevin J, Cannon, Christopher P, Henry, Timothy D, Fonarow, Gregg C, Choudhry, Niteesh K, Fonseca, Eileen, Bhalla, Narinder, Eudicone, James M, Peterson, Eric D, Wang, Tracy Y

“…Background Hospitals commonly provide a short-term supply of free P2Y inhibitors at discharge after myocardial infarction, but it is unclear if these programs…”
Get full text

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study by Ibrahim, Homam, Sharma, Praneet K., Cohen, David J., Fonarow, Gregg C., Kaltenbach, Lisa A., Effron, Mark B., Zettler, Marjorie E., Peterson, Eric D., Wang, Tracy Y.

“…Background Among patients with acute myocardial infarction (MI) who have multivessel disease, it is unclear if multivessel percutaneous coronary intervention…”
Get full text

Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE‐ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study by Fanaroff, Alexander C., Kaltenbach, Lisa A., Peterson, Eric D., Akhter, Mohammed W., Effron, Mark B., Henry, Timothy D., Wang, Tracy Y.

“…Background Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI), yet little guidance is provided on antiplatelet management…”
Get full text

Magnitude and Characteristics of Patients Who Survived an Acute Myocardial Infarction by Tisminetzky, Mayra, Wang, Tracy Y., Gurwitz, Jerry, Kaltenbach, Lisa A., McManus, David, Gore, Joel, Peterson, Eric, Goldberg, Robert J.

“…Background The purpose of this study was to describe the magnitude and characteristics of patients who did not experience any significant major adverse…”
Get full text

An algorithm to identify incident myocardial infarction using Medicaid data by Choma, Neesha N., Griffin, Marie R., Huang, Robert L., Mitchel, Edward F., Kaltenbach, Lisa A., Gideon, Patricia, Stratton, Shannon M., Roumie, Christianne L.

“…Purpose Studies of non‐steroidal anti‐inflammatory drugs (NSAIDs) and cardiovascular events using administrative data require identification of incident acute…”
Get full text

Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial by DeVore, Adam D, Granger, Bradi B, Fonarow, Gregg C, Al-Khalidi, Hussein R, Albert, Nancy M, Lewis, Eldrin F, Butler, Javed, Piña, Ileana L, Allen, Larry A, Yancy, Clyde W, Cooper, Lauren B, Felker, G. Michael, Kaltenbach, Lisa A, McRae, A. Thomas, Lanfear, David E, Harrison, Robert W, Disch, Maghee, Ariely, Dan, Miller, Julie M, Granger, Christopher B, Hernandez, Adrian F

“…IMPORTANCE: Adoption of guideline-directed medical therapy for patients with heart failure is variable. Interventions to improve guideline-directed medical…”
Get full text

Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention: An Updated Report from the National Cardiovascular Data Registry (2007―2012) by FELDMAN, Dmitriy N, SWAMINATHAN, Rajesh V, PIANA, Robert N, HILLEGASS, William B, COHEN, Mauricio G, GILCHRIST, Ian C, RAO, Sunil V, KALTENBACH, Lisa A, BAKLANOV, Dmitri V, KIM, Luke K, CHIU WONG, S, MINUTELLO, Robert M, MESSENGER, John C, MOUSSA, Issam, GARRATT, Kirk N

“…Radial access for percutaneous coronary intervention (r-PCI) is associated with reduced vascular complications; however, previous reports have shown that <2%…”
Get full text

Downstream Testing and Subsequent Procedures After Coronary Computed Tomographic Angiography Following Coronary Stenting in Patients ≥65 Years of Age by Mudrick, Daniel, MD, MPH, Kaltenbach, Lisa A., MS, Shah, Bimal, MD, MBA, Lytle, Barbara, MS, Masoudi, Frederick A., MD, MSPH, Mark, Daniel B., MD, Federspiel, Jerome J., AB, Cowper, Patricia A., PhD, Green, Cynthia, PhD, Douglas, Pamela S., MD

“…Limited data are available on the use of coronary computed tomographic angiography (CCTA) in patients who have received percutaneous coronary intervention…”
Get full text

Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial by Wang, Tracy Y, Kaltenbach, Lisa A, Cannon, Christopher P, Fonarow, Gregg C, Choudhry, Niteesh K, Henry, Timothy D, Cohen, David J, Bhandary, Durgesh, Khan, Naeem D, Anstrom, Kevin J, Peterson, Eric D

“…IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y12 inhibitor therapy earlier than the recommended 1 year after myocardial…”
Get full text

Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention: Report From the NCDR CathPCI Registry by Fanaroff, Alexander C, Zakroysky, Pearl, Wojdyla, Daniel, Kaltenbach, Lisa A, Sherwood, Matthew W, Roe, Matthew T, Wang, Tracy Y, Peterson, Eric D, Gurm, Hitinder S, Cohen, Mauricio G, Messenger, John C, Rao, Sunil V

“…BACKGROUND:Although many studies show an inverse association between operator procedural volume and short-term adverse outcomes after percutaneous coronary…”
Get full text

The Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction by Baklanov, Dmitri V., MD, Kaltenbach, Lisa A., MS, Marso, Steven P., MD, Subherwal, Sumeet S., MD, Feldman, Dmitriy N., MD, Garratt, Kirk N., MD, Curtis, Jeptha P., MD, Messenger, John C., MD, Rao, Sunil V., MD

“…Objectives The purpose of this study was to examine use and describe outcomes of radial access for percutaneous coronary intervention (PCI) in patients with…”
Get full text

Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention by Borden, William B, Redberg, Rita F, Mushlin, Alvin I, Dai, David, Kaltenbach, Lisa A, Spertus, John A

“…CONTEXT The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study, which provided optimal medical therapy (OMT) to all…”
Get full text

The Prevalence and Outcomes of Transradial Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Analysis From the National Cardiovascular Data Registry (2007 to 2011) by BAKLANOV, Dmitri V, KALTENBACH, Lisa A, MARSO, Steven P, SUBHERWAL, Sumeet S, FELDMAN, Dmitriy N, GARRATT, Kirk N, CURTIS, Jeptha P, MESSENGER, John C, RAO, Sunil V

“…The purpose of this study was to examine use and describe outcomes of radial access for percutaneous coronary intervention (PCI) in patients with ST-segment…”
Get full text